Tigecycline treatment of multi-drug-resistant Corynebacterium jeikeium infection in a child with relapsing and refractory acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 55, Issue 2, 2010, Pages 349-351

  Dinleyici, Ener Cagri ^a   Yargic, Zeynel Abidin ^a   Bor, Ozcan ^a   Kiremitci, Abdurrahman ^a   Durmaz, Gul ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Children; Corynebacterium jeikeium; Leukemia; Tigecycline

Indexed keywords

AMIKACIN; CASPOFUNGIN; CEFEPIME; MEROPENEM; METRONIDAZOLE; TIGECYCLINE; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; CANCER RELAPSE; CASE REPORT; CENTRAL VENOUS CATHETER; CHILD; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTION; CORYNEBACTERIUM JEIKEIUM; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPSILOMETER TEST; FEMALE; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CORYNEBACTERIUM INFECTIONS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MINOCYCLINE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION;

EID: 77955108818     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22527     Document Type: Article

References (21)

1. Giamarellou H. Treatment options for multidrug-resistant bacteria. Expert Rev Anti Infect Ther 2006;4:601-618.
2. Meckler G, Lindemulder S. Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am 2009;27:525-544.
3. Falagas ME, Metaxas EI. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization. Expert Rev Anti Infect Ther 2009;7:913-923.
4. Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother 2009;63:775-780.
5. Karageorgopoulos DE, Falagas ME. New antibiotics: Optimal use in current clinical practice. Int J Antimicrob Agents 2009;34:S55-S62.
6. Nicolau DP. Management of complicated infections in the era of antimicrobial resistance: The role of tigecycline. Expert Opin Pharmacother 2009;10:1213-1222.
7. Pankey GA, Steele RW. Tigecycline: A single antibiotic for polymicrobial infections. Pediatr Infect Dis J 2007;26:77-78.
8. Peterson LR. A review of tigecycline - The first glycylcycline. Int J Antimicrob Agents 2008;32:S215-S222.
9. Poulakou G, Kontopidou FV, Paramythiotou E, et al. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect 2009;58:273-284.
10. Salas C, Calvo J, Martinez-Martinez L. Activity of tigecycline against coryneform bacteria of clinical interest and Listeria monocytogenes. Antimicrob Agents Chemother 2008;52:1503-1505.
11. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline M45-A.Wayne, PA: Clinical and Laboratory Standards Institute.
12. Fosi-Mbantenkhu J, Orett F. Predisposition to Corynebacterium jeikeium infection in acute lymphoblastic leukemia: A report of two cases in Trinidad. Med Pediatr Oncol 1994;22:350-354. (Pubitemid 24105218)
13. Rozdzinski E, Kern W, Schmeiser T, et al. Corynebacterium jeikeium bacteremia at a tertiary care center. Infection 1991;19:201-204.
14. Umeh OC, Kubak BM, Pegues DA, et al. Corynebacterium jeikeium sepsis after 8-methoxypsolaren photopheresis for cutaneous T-cell lymphoma. Diagn Microbiol Infect Dis 2004;50:71-72.
15. van der Lelie H, Hall M, Mertens M, et al. Corynebacterium CDC group JK (Corynebacterium jeikeium) sepsis in haematological patients: A report of three cases and a systematic literature review. Scand J Infect Dis 1995;27:581-584.
16. Wang CC, Mattson D, Wald A. Corynebacterium jeikeium bacteremia in bone marrowtransplant patients with Hickman catheters. Bone Marrow Transplant 2001;27:445-449.
17. Schoen C, Unzicker C, Stuhler G, et al. Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient. J Clin Microbiol 2009;47:2328-2331.
18. Gardiner D, Dukart G, Cooper A, et al. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: Pooled results from 8 phase III clinical trials. Clin Infect Dis 2010;50:229-238.
19. Jaspan HB, Brothers AW, Campbell AJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: Characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010;29: (Epub ahead of print) DOI: 10.1097/INF.0b013e3181c806d8.
20. Chemaly RF, Hanmod SS, Jiang Y, et al. Tigecycline use in cancer patients with serious infections: A report on 110 cases from a single institution. Medicine (Baltimore) 2009;88:211-220.
21. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-208.